Showing 1 - 3 results of 3 for search 'Laurence Duplomb', query time: 0.02s Refine Results
  1. 1
    A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma

    A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma by Manon Durand, Vincent Cabaud Gibouin, Laurence Duplomb, Leila Salmi, Mélody Caillot, Brigitte Sola, Vincent Camus, Fabrice Jardin, Carmen Garrido, Gaëtan Jego

    Published 2024-05-01
    Get full text
    Article
  2. 2
    P1217: TARGETING HSP110 IN COMBINATION WITH SELINEXOR IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA AND IN CLASSICAL HODGKIN LYMPHOMA INHIBITS STAT6 ACTIVATION AND IMPAIRS LYMPHOMA CELL GROWTH

    P1217: TARGETING HSP110 IN COMBINATION WITH SELINEXOR IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA AND IN CLASSICAL HODGKIN LYMPHOMA INHIBITS STAT6 ACTIVATION AND IMPAIRS LYMPHOMA CELL G... by Manon Durand, Vincent Cabaud Gibouin, Vincent Camus, Leila Salmi, Laurence Duplomb, Pierre-Julien Viailly, Fabrice Jardin, Brigitte Sola, Carmen Garrido, Gaetan Jego

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Characterization of Vps13b-mutant mice reveals neuroanatomical and behavioral phenotypes with females less affected

    Characterization of Vps13b-mutant mice reveals neuroanatomical and behavioral phenotypes with females less affected by Charlotte Montillot, Emilia Skutunova, Ayushma, Morgane Dubied, Adam Lahmar, Sylvie Nguyen, Benazir Peerally, Fabrice Prin, Yannis Duffourd, Christel Thauvin-Robinet, Laurence Duplomb, Heng Wang, Muhammad Ansar, Laurence Faivre, Nicolas Navarro, Shilpi Minocha, Stephan C. Collins, Binnaz Yalcin

    Published 2023-09-01
    Get full text
    Article

Search Tools: